A group of industry stakeholders spoke and outlined recommendations for lawmakers. This is about two hours, 40 minutes. We will come to order. I recognize myself for five minutes. Opening statement. Todays hearing marks the health of subsidy public discussion on modernizing the Current System of the United States fda to review, approve and update. This hearing provides us in the American Public with the opportunity to better understand the fda regulatory frame work for overthecounter drugs and consider a proposal to reform the monograph system. I would like to commend all for their efforts in offering their insight to the committee. Theyve set a strong record of bipartisanship on Public Health issues such as 21st century cures, the fda reauthorization act and i hope to add to that record of success with todays hearing. Overthecounter drug products provide a wide variety of ailments. Pain relievers, eyedrops, cough drops as a firstline treatment option before going to see the dr. And ge
Minutes. Subcommittee on health will now come to order. Ill recognize myself five minutes for an Opening Statement. Todays hearing marks the Health Subcommittees first public discussion on modernizing the Current System at the United States food and Drug Administration to review, approve and update overthecounter drugs. This hearing provides us and the American Public with an opportunity to better understand the food and Drug Administrations Regulatory Framework to regulate overthecounter drugs and to consider a proposal to reform the monograph system. Today we will convene two panels of witnesses. First i want to welcome dr. Woodcome back to our subcommittee woodcock back to our subcommittee. Later we will hear from other key stakeholders, and i would like to commend all for their efforts throughout the negotiation process and for offering their insight to the committee. Both the energy and Commerce Health subcommittee and the full committee have a strong record of bipartisanship on i